已收录 268921 条政策
 政策提纲
  • 暂无提纲
Improvement of Ischemic Myocardial Dysfunction by Nisoldipine in Relation to Its Coronary Vasodilating Action
[摘要] References(24)Cited-By(2)We examined the cardioprotective effect of nisoldipine against myocardial dysfunction during ischemia and reperfusion in comparison with those of diltiazem and nifedipine in rabbit hearts perfused at constant pressure. These calcium antagonists were administered to the hearts before 60 min of ischemia. They inhibited the increase of end-diastolic pressure during ischemia in a dose-dependent manner. Diltiazem at 1.0 μM, nifedipine at 3.0 μM and nisoldipine at 0.01 μM produced the maximal cardioprotec tive effect. Nisoldipine had a beneficial effect with less negative inotropic effect than those of diltiazem and nifedipine and it produced a significant increase of coronary flow during reperfusion. When the vascular component was eliminated under constant flow perfusion, nisoldipine also showed the cardioprotective effect. Nisoldipine did not produce any beneficial effect without the inhibition of the increase in end-diastolic pressure during ischemia nor did it do so without the increase of reperfusion flow. Therefore, the nisoldipine-increased coronary flow during reperfusion as well as the inhibition of ischemic contracture by nisoldipine seems to play a crucial role in improving the myocardial dysfunction of ischemic-reperfused hearts.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] Nisoldipine;Ischemic myocardial function;Coronary vasodilating action;Heart (rabbit;perfused) [时效性] 
   浏览次数:5      统一登录查看全文      激活码登录查看全文